Strategic gathering of patient and family data can help determine if we need to be on the lookout for other types of tumors in carriers, and further knowledge is needed to better understand why loss of SMARCE1 expression specifically leads to CCMs. The gene discussed is SMARCE1; the disease is cerebrocostomandibular syndrome.